{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:31:35Z","timestamp":1786984295636,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T00:00:00Z","timestamp":1551484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.alit.2019.03.001","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T09:36:13Z","timestamp":1553247373000},"page":"437-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Eosinophilic fasciitis: From pathophysiology to treatment"],"prefix":"10.1016","volume":"68","author":[{"given":"Hironobu","family":"Ihn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2019.03.001_bib1","first-page":"70","article-title":"Diffuse fasciitis with eosinophilia: a new syndrome?","volume":"88","author":"Shulman","year":"1975","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1016\/j.alit.2019.03.001_bib2","first-page":"525","article-title":"Proceedings: eosinophilic fasciitis. Report of six cases of a newly recognized scleroderma-like syndrome","volume":"18","author":"Rodnan","year":"1975","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.alit.2019.03.001_bib3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/art.1780240508","article-title":"Eosinophilic fasciitis: clinical, laboratory, and microscopic considerations","volume":"24","author":"Kent","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.alit.2019.03.001_bib4","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/art.1780251006","article-title":"Circulating immune complexes in eosinophilic fasciitis","volume":"25","author":"Seibold","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.alit.2019.03.001_bib5","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/archderm.1990.01670290057008","article-title":"Eosinophilic fasciitis. Increased collagen production and type I procollagen messenger RNA levels in fibroblasts cultured from involved skin","volume":"126","author":"Kahari","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.alit.2019.03.001_bib6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2133.2004.06062.x","article-title":"Serum levels of tissue inhibitor of metalloproteinase-1 and 2 in patients with eosinophilic fasciitis","volume":"151","author":"Jinnin","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2019.03.001_bib7","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/ard.55.12.935","article-title":"Serum and synovial fluid levels of interleukin-5 in a patient with eosinophilic fasciitis","volume":"55","author":"Nishiya","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.alit.2019.03.001_bib8","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/art.1780251111","article-title":"Serum eosinophilotactic activity in eosinophilic fasciitis","volume":"25","author":"Wasserman","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.alit.2019.03.001_bib9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/archderm.1989.01670180077010","article-title":"Increased plasma histamine level in eosinophilic fasciitis","volume":"125","author":"Falanga","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.alit.2019.03.001_bib10","first-page":"75","article-title":"Analysis of leukemia inhibitory factor, type 1 and type 2 cytokine production in patients with eosinophilic fasciitis","volume":"28","author":"Viallard","year":"2001","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.alit.2019.03.001_bib11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/ard.62.2.190","article-title":"Circulating soluble CD40 ligand in patients with eosinophilic fasciitis","volume":"62","author":"Jinnin","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.alit.2019.03.001_bib12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10067-003-0781-7","article-title":"Elevated serum levels of manganese superoxide dismutase in patients with eosinophilic fasciitis","volume":"22","author":"Jinnin","year":"2003","journal-title":"Clin Rheum"},{"key":"10.1016\/j.alit.2019.03.001_bib13","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/cup.12947","article-title":"Th1- and Th-17-polarized immune infiltrates in eosinophilic fasciitis \u2013 a potential marler for histopathologic distinction from morphea","volume":"44","author":"Moy","year":"2017","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.alit.2019.03.001_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jaad.2017.06.148","article-title":"Clinicopathologic and immunophenotypic features of eosinophilic fasciitis and morphea profunda: a comparative study of 27 cases","volume":"78","author":"Onajin","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2019.03.001_bib15","first-page":"482","article-title":"Increased expression of transforming growth factor-\u03b21, fibronectin, and type I, III, and VI collagen genes in fascial fibroblasts from patients with diffuse fasciitis with eosinophilia","volume":"23","author":"Kahari","year":"1996","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.alit.2019.03.001_bib16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/1523-1747.ep12345771","article-title":"Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders","volume":"106","author":"Igarashi","year":"1996","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2019.03.001_bib17","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/1346-8138.14160","article-title":"Diagnostic criteria, severity classifications, and clinical guidelines of eosinophilic fasciitis","volume":"45","author":"Jinnin","year":"2018","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.alit.2019.03.001_bib18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/1346-8138.14162","article-title":"Diagnostic criteria, severity classifications, and clinical guidelines of systemic sclerosis","volume":"45","author":"Asano","year":"2018","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.alit.2019.03.001_bib19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/1346-8138.14161","article-title":"Diagnostic criteria, severity classifications, and clinical guidelines of localized scleroderma","volume":"45","author":"Asano","year":"2018","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.alit.2019.03.001_bib20","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/1346-8138.14171","article-title":"Diagnostic criteria, severity classifications, and clinical guidelines of lichen sclerosus et atrophicus","volume":"45","author":"Hasegawa","year":"2018","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.alit.2019.03.001_bib21","first-page":"563","article-title":"Serum aldolase level is a useful indicator of disease activity in eosinophilic fasciitis","volume":"22","author":"Fujimoto","year":"1995","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.alit.2019.03.001_bib22","first-page":"1367","article-title":"Serum PIIIP levels reflect disease activity in eosinophilic fasciitis","volume":"25","author":"Kato","year":"2003","journal-title":"Pract Dermatol"},{"key":"10.1016\/j.alit.2019.03.001_bib23","first-page":"1270","article-title":"Magnetic resonance imaging in the evaluation of patients with eosinophilic fasciitis","volume":"16","author":"Offel","year":"1989","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.alit.2019.03.001_bib24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2133.1997.tb14929.x","article-title":"Eosinophilic fasciitis with myelodysplasia responsive to treatment with cyclosporine","volume":"136","author":"Fleming","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2019.03.001_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000093847","article-title":"Eosinophilic fasciitis 30 years after \u2013 what do we really know? Report of 11 patients and review of the literature","volume":"213","author":"Antic","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.alit.2019.03.001_bib26","first-page":"1967","article-title":"Response to methotrexate in a patient with idiopathic eosinophilic fasciitis, morphea, IgM hypergammaglobulinemia, and renal involvement","volume":"22","author":"Janzen","year":"1995","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.alit.2019.03.001_bib27","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1365-2133.2000.03431.x","article-title":"Eosinophilic fasciitis treated with psoralen-ultraviolet A bath photochemotherapy","volume":"142","author":"Schiener","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2019.03.001_bib28","first-page":"591","article-title":"A\u00a0case of eosinophilic fasciitis accompanied by morphea","volume":"43","author":"Asano","year":"2001","journal-title":"Pract Dermatol"},{"key":"10.1016\/j.alit.2019.03.001_bib29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0190-9622(98)70091-X","article-title":"Systemic lupus erythematosus after eosinophilic faciitis: a case report","volume":"39","author":"Gallardo","year":"1998","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2019.03.001_bib30","first-page":"1383","article-title":"Rheumatoid arthritis with eosinophilic faciitis and pure red aplasia","volume":"16","author":"Markusse","year":"1989","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.alit.2019.03.001_bib31","first-page":"57","article-title":"Sj\u00f6gren\u2019s syndrome associated with eosinophilic faciitis","volume":"171","author":"Pamies","year":"1983","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.alit.2019.03.001_bib32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3904\/kjim.2005.20.2.180","article-title":"Eosinophilic faciitis associated with autoimmune thyroiditis","volume":"20","author":"Hur","year":"2005","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.alit.2019.03.001_bib33","first-page":"730","article-title":"Eosinophilic faciitis and anaplastic anaemia","volume":"7","author":"Littlejohn","year":"1980","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.alit.2019.03.001_bib34","first-page":"1864","article-title":"Autoimmune hemolytic anaemia associated with eosinophilic faciitis","volume":"25","author":"Gracia","year":"1998","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.alit.2019.03.001_bib35","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000018271","article-title":"Eosinophilic faciitis following idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia and Hashimoto's disease","volume":"199","author":"Bachmeyer","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.alit.2019.03.001_bib36","first-page":"473","article-title":"Eosinophilic faciitis complicated by Hodgkin's disease","volume":"9","author":"Michaels","year":"1982","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.alit.2019.03.001_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2133.1997.tb14929.x","article-title":"Eosinophilic faciitis with myelodysplasia responsive to treatment with cyclosporin","volume":"136","author":"Fleming","year":"1997","journal-title":"Br J Dermatol"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893019300218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893019300218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:09:36Z","timestamp":1761156576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893019300218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1323893019300218"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2019.03.001","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eosinophilic fasciitis: From pathophysiology to treatment","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2019.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society of Allergology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}